2023 annual financial data
MIRA Pharmaceuticals 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -8,526,049 USD and net income was -11,982,343 USD.
Operating cash flow was -4,532,403 USD.
Get free MIRA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,526,049 USD
- Net income
- -11,982,343 USD
- Operating cash flow
- -4,532,403 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all MIRA Pharmaceuticals financial years